Cornerstone Therapeutics Articles
Italy's Chiesi seeking to take full control of Cornerstone Thera
20 February 2013
Cornerstone Thera gets US rights to Chiesi's Bethkis
11 November 2012
FDA advisory negative on Cornerstone's lixivaptan
17 September 2012
Cornerstone acquires Cardiokine
4 January 2012
Showing 1-6 of 6 articles
- 1
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
